Seer to Participate in Upcoming November Investor Conferences

Rhea-AI Summary

Seer (Nasdaq: SEER) announced that company management will participate in two investor conferences in November 2025: the UBS Global Healthcare Conference in Palm Beach Gardens, FL with 1x1 meetings on Wednesday, November 12, 2025, and the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum in New York with a fireside chat on Thursday, November 20, 2025 at 4:00 p.m. ET. Live webcasts will be available on the company's investor site investor.seer.bio, and archived replays will be posted on the company website after each conference.

REDWOOD CITY, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced company management will be participating in the following investor conferences:

• UBS Global Healthcare Conference in Palm Beach Gardens, FL
  Hosting 1x1 meetings on Wednesday, November 12^th

• Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum in New York, NY
  Fireside chat on Thursday, November 20^th at 4:00 p.m. Eastern Time

Live webcasts of the sessions will be available on the Investor section of Seer’s website at investor.seer.bio. Archived replays will be available on the company’s website following the conference.

About Seer
Seer, Inc. (Nasdaq: SEER) sets the standard in deep, unbiased proteomics—delivering insights with scale, speed, precision, and reproducibility previously unattainable by other proteomic methods. Seer’s Proteograph Product Suite uniquely integrates proprietary engineered nanoparticles, streamlined automation instrumentation, optimized consumables, and advanced analytical software to solve challenges conventional methods have failed to overcome. Traditional proteomic technologies have struggled with inconsistent data, limited throughput, and prohibitive complexity, but Seer’s robust and scalable workflow consistently reveals biological insights that others do not. Seer’s products are for research use only and are not intended for diagnostic procedures. For more information about Seer’s differentiated approach and ongoing leadership in proteomics, visit www.seer.bio.

Media Contact:
Patrick Schmidt
pr@seer.bio

Investor Contact:
Carrie Mendivil
investor@seer.bio

FAQ

When will Seer (SEER) present at the UBS Global Healthcare Conference in November 2025?

Seer management will host 1x1 meetings at the UBS Global Healthcare Conference on Wednesday, November 12, 2025.

What time is Seer's (SEER) fireside chat at the Canaccord Genuity MedTech forum?

The fireside chat is scheduled for Thursday, November 20, 2025 at 4:00 p.m. Eastern Time.

Where can investors watch Seer (SEER) presentations live or on replay?

Live webcasts and archived replays will be available via the investor site at investor.seer.bio.

Which investor conferences will Seer (SEER) attend in November 2025?

Seer will attend the UBS Global Healthcare Conference in Palm Beach Gardens, FL and the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum in New York.

Will Seer (SEER) hold one-on-one investor meetings at the November conferences?

Yes, Seer will host 1x1 meetings at the UBS Global Healthcare Conference on November 12, 2025.